What Are the Benefits of Annex 1 for the Pharmaceutical Industry? Enhanced patient safety with stringent contamination controls Harmonization of regulations across EU member states Encouragement of technological innovation in manufacturing Risk-based quality management for tailored approaches Expanded guidance covering a…
Explore Innovations in Pharma Visual Inspection
Visual Inspection in Pharma 2025: Innovations Shaping the Future of Quality Control Embrace technology: Invest in AI and machine learning capabilities to optimize inspection processes and improve defect detection. Consider outsourcing: Leverage CDMOs or CMOs for visual inspection services to ensure…
The Future of Quality Assurance in Pharma
Visual Inspection in Pharma 2025: The Future of Quality Assurance Global healthcare visual inspection services market expected to grow from $4.01 billion in 2024 with a CAGR of 9.97% through 2030. Emerging technologies like AI and automation are transforming visual inspection…
